SCHEMBL8539715

SCHEMBL8539715

CCCN(c1ccncc1)n1ccc2cc(OC(=O)N(C)C)ccc21

nearest known ligand 0.71

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 14/20 0.71
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
NCEH1 Q6PIU2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539620 0.89 SLC6A2 (0.65) SLC6A2
SCHEMBL8539631 0.88 SLC6A2 (0.65) SLC6A2MAOAMAOB
SCHEMBL8538709 0.87 SLC6A2 (0.70) SLC6A2
SCHEMBL9738329 0.86 SLC6A2 (0.69) SLC6A2
SCHEMBL8544459 0.85 SLC6A2 (0.67) SLC6A2
Hydrochloric Acid SCHEMBL8542999 0.85 SLC6A2 (0.67) SLC6A2
SCHEMBL8546133 0.85 SLC6A2 (0.67) SLC6A2
SCHEMBL9738440 0.84 SLC6A2 (0.66) SLC6A2
SCHEMBL8538364 0.84 SLC6A2 (0.66) SLC6A2
SCHEMBL7609768 0.83 SLC6A2 (1.00) SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5102891-A Useful for treating various memory dysfunctions such as alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-07 US claimed
EP-0468401-B1 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-09-16 EP disclosed
US-5102891-A Useful for treating various memory dysfunctions such as alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-07 US disclosed
EP-0468401-A2 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-01-29 EP disclosed